NasdaqCM - Nasdaq Real Time Price USD
Plus Therapeutics, Inc. (PSTV)
0.2990
-0.0140
(-4.47%)
At close: May 23 at 4:00:00 PM EDT
0.3030
+0.00
+(1.34%)
After hours: May 23 at 7:54:55 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 3 | 3 |
Avg. Estimate | -0.29 | -0.26 | -0.96 | -0.88 |
Low Estimate | -0.55 | -0.45 | -1.54 | -1.14 |
High Estimate | -0.09 | -0.1 | -0.34 | -0.53 |
Year Ago EPS | -0.75 | -0.45 | -1.95 | -0.96 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 1.11M | 1.14M | 4.86M | 5.28M |
Low Estimate | -- | -- | -- | -- |
High Estimate | 2.2M | 2.3M | 11.45M | 12.11M |
Year Ago Sales | 1.68M | 1.28M | 5.82M | 4.86M |
Sales Growth (year/est) | -33.66% | -11.06% | -16.51% | 8.56% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | -1.09 | -0.53 | -0.56 | -0.5 |
EPS Actual | -0.75 | -0.45 | -0.37 | -0.49 |
Difference | 0.34 | 0.08 | 0.19 | 0.01 |
Surprise % | 31.19% | 15.09% | 34.22% | 1.34% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.29 | -0.26 | -0.96 | -0.88 |
7 Days Ago | -0.34 | -0.31 | -0.94 | -0.83 |
30 Days Ago | -0.5 | -0.47 | -2.1 | -2.43 |
60 Days Ago | -0.5 | -0.47 | -2.1 | -2.43 |
90 Days Ago | -0.5 | -0.47 | -2.1 | -2.43 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | -- | 2 |
Up Last 30 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PSTV | 60.89% | 42.22% | 50.77% | 7.99% |
S&P 500 | 12.65% | 2.49% | 7.39% | 14.05% |
Upgrades & Downgrades
Downgrade | D. Boral Capital: Buy to Hold | 5/5/2025 |
Maintains | Ascendiant Capital: Buy to Buy | 4/21/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/28/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/21/2025 |
Initiated | D. Boral Capital: Buy | 3/17/2025 |
Related Tickers
ACOG Alpha Cognition Inc. Common Stock
9.14
+5.18%
APVO Aptevo Therapeutics Inc.
0.2754
-8.20%
BDRX Biodexa Pharmaceuticals Plc
1.1500
-17.27%
ADTX Aditxt, Inc.
1.7400
-4.40%
RNAZ TransCode Therapeutics, Inc.
6.97
-8.53%
NCNA NuCana plc
0.0380
-3.55%
PLRZ Polyrizon Ltd.
0.0034
-19.05%
ONCO Onconetix, Inc.
0.0725
-14.00%
PHIO Phio Pharmaceuticals Corp.
1.7500
-4.89%
ABP Abpro Corporation
0.2120
-7.83%